Found: 75
Select item for more details and to access through your institution.
The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: A 30‐year experience.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. 1204, doi. 10.1002/ajh.26287
- By:
- Publication type:
- Article
The Berlin‐Frankfurt‐Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 8, p. E209, doi. 10.1002/ajh.25152
- By:
- Publication type:
- Article
Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: Experience on 142 patients.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 11, p. E273, doi. 10.1002/ajh.23540
- By:
- Publication type:
- Article
Rituximab Combined With MACOP-B or VACOP-B and Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 5, p. 381, doi. 10.3816/CLM.2009.n.074
- By:
- Publication type:
- Article
Bronchus-Associated Lymphoid Tissue Lymphomas: An Update of a Rare Extranodal Maltoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 9, p. 566
- By:
- Publication type:
- Article
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature.
- Published in:
- Rheumatology International, 2012, v. 32, n. 7, p. 2209, doi. 10.1007/s00296-011-1998-4
- By:
- Publication type:
- Article
Treatment with siltuximab determined long-lasting complete remission in a multiply relapsing systemic Castleman disease patient.
- Published in:
- Current Therapeutics, 2022, v. 25, n. 5, p. 6
- By:
- Publication type:
- Article
Pharmacoutilization of epoetins in naïve patients with hematological malignancies in an unselected Italian population under clinical practice setting: a comparative analysis between originator and biosimilars.
- Published in:
- Biologics: Targets & Therapy, 2016, v. 10, p. 157, doi. 10.2147/BTT.S114625
- By:
- Publication type:
- Article
Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report.
- Published in:
- Chemotherapy (0009-3157), 2024, v. 69, n. 1, p. 23, doi. 10.1159/000534784
- By:
- Publication type:
- Article
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 11, p. e817, doi. 10.1016/j.clml.2021.06.017
- By:
- Publication type:
- Article
New Agents in Marginal Zone Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S61, doi. 10.1016/S2152-2650(21)01211-8
- By:
- Publication type:
- Article
Intravascular Large B-cell Lymphoma Successfully Treated with Autologous Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 8, p. e678, doi. 10.1016/j.clml.2021.04.002
- By:
- Publication type:
- Article
Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case Report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Complete Response of Relapsed Systemic and Cutaneous Anaplastic Large Cell Lymphoma Using Brentuximab Vedotin: 2 Case Reports.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 4, p. 493, doi. 10.1016/j.clml.2013.03.008
- By:
- Publication type:
- Article
Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 6, p. 462, doi. 10.1016/j.clml.2011.02.001
- By:
- Publication type:
- Article
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 5, p. 899, doi. 10.1007/s00428-022-03455-9
- By:
- Publication type:
- Article
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 12, p. 1, doi. 10.1038/s41408-022-00760-z
- By:
- Publication type:
- Article
Cutaneous adverse‐events in patients treated with Ibrutinib.
- Published in:
- Dermatologic Therapy, 2020, v. 33, n. 6, p. 1, doi. 10.1111/dth.14190
- By:
- Publication type:
- Article
BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1043, doi. 10.1007/s00432-022-03955-w
- By:
- Publication type:
- Article
The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation.
- Published in:
- Oncologist, 2024, v. 29, n. 6, p. e789, doi. 10.1093/oncolo/oyae017
- By:
- Publication type:
- Article
Lenalidomide in Pretreated Patients with Diffuse Large B‐Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice.
- Published in:
- Oncologist, 2019, v. 24, n. 9, p. 1246, doi. 10.1634/theoncologist.2018-0603
- By:
- Publication type:
- Article
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
- Published in:
- Oncologist, 2018, v. 23, n. 9, p. 1033, doi. 10.1634/theoncologist.2017-0597
- By:
- Publication type:
- Article
Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients.
- Published in:
- Oncologist, 2016, v. 21, n. 12, p. 1436, doi. 10.1634/theoncologist.2016-0112
- By:
- Publication type:
- Article
Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients.
- Published in:
- Oncologist, 2015, v. 20, n. 12, p. 1413, doi. 10.1634/theoncologist.2015-0227
- By:
- Publication type:
- Article
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma.
- Published in:
- Oncologist, 2014, v. 19, n. 7, p. 746, doi. 10.1634/theoncologist.2013-0463
- By:
- Publication type:
- Article
Management of central nervous system relapse in a young patient affected by primary mediastinal large B‐cell lymphoma: A case report.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 6, p. 933, doi. 10.1002/ccr3.2706
- By:
- Publication type:
- Article
Effectiveness of chemotherapy after anti‐PD‐1 blockade failure for relapsed and refractory Hodgkin lymphoma.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 21, p. 7830, doi. 10.1002/cam4.3262
- By:
- Publication type:
- Article
90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 6, p. 1093, doi. 10.1002/cam4.684
- By:
- Publication type:
- Article
Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?
- Published in:
- Current Hematologic Malignancy Reports, 2021, v. 16, n. 1, p. 82, doi. 10.1007/s11899-021-00609-5
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection and vaccination in patients with hairy‐cell leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 3, p. 411, doi. 10.1111/bjh.18606
- By:
- Publication type:
- Article
<sup>90</sup>Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma) — The Zeno Study.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 1, p. e6, doi. 10.1111/bjh.16404
- By:
- Publication type:
- Article
The role of transplantation in Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 1, p. 93, doi. 10.1111/bjh.15639
- By:
- Publication type:
- Article
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 4, p. 625, doi. 10.1111/bjh.12894
- By:
- Publication type:
- Article
Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 5, p. 681, doi. 10.1111/bjh.12548
- By:
- Publication type:
- Article
Hair and Scalp Manifestations in Secondary Syphilis: Epidemiology, Clinical Features and Trichoscopy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Primary Bone Lymphoma: Evaluation of Chemoimmunotherapy as Front-line Treatment in 21 Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 4, p. 321, doi. 10.1016/j.clml.2011.03.021
- By:
- Publication type:
- Article
Local Versus Systemic Treatment for Primary Cutaneous B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, p. S103, doi. 10.3816/CLML.2010.s.020
- By:
- Publication type:
- Article
Yttrium-90 Ibritumomab Tiuxetan as a Single Agent in Patients With Pretreated B-Cell Lymphoma: Evaluation of the Long-Term Outcome.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 4, p. 258, doi. 10.3816/CLML.2010.n.054
- By:
- Publication type:
- Article
Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Midtreatment.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 5, p. 1010, doi. 10.1002/cncr.25579
- By:
- Publication type:
- Article
Immunophenotype and Intermediate-High International Prognostic Index Score Are Prognostic Factors for Therapy in Diffuse Large B-Cell Lymphoma Patients.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 24, p. 5667, doi. 10.1002/cncr.25307
- By:
- Publication type:
- Article
Hairy Cell Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 20, p. 4788, doi. 10.1002/cncr.25243
- By:
- Publication type:
- Article
Erythematous induration of the chest.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2015, v. 13, n. 12, p. 1291, doi. 10.1111/ddg.12763
- By:
- Publication type:
- Article
Erythematöse Induration im Brustbereich.
- Published in:
- Journal der Deutschen Dermatologischen Gesellschaft, 2015, v. 13, n. 12, p. 1291, doi. 10.1111/ddg.80_12763
- By:
- Publication type:
- Article
Diagnostic accuracy of positron emission tomography/computed tomography-driven biopsy for the diagnosis of lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3058, doi. 10.1007/s00259-020-04913-9
- By:
- Publication type:
- Article